Boyd Dialysis in Bangor, Maine - Dialysis Center

Boyd Dialysis is a medicare approved dialysis facility center in Bangor, Maine and it has 20 dialysis stations. It is located in Penobscot county at Dialysis Unit, Bangor, ME, 04401. You can reach out to the office of Boyd Dialysis at (207) 941-1298. This dialysis clinic is managed and/or owned by Davita. Boyd Dialysis has the following ownership type - Profit. It was first certified by medicare in July, 2013. The medicare id for this facility is 202512 and it accepts patients under medicare ESRD program.

Dialysis Center Profile

NameBoyd Dialysis
LocationDialysis Unit, Bangor, Maine
No. of Dialysis Stations 20
Medicare ID202512
Managed ByDavita
Ownership TypeProfit
Late Shifts No

Contact Information


Dialysis Unit, Bangor, Maine, 04401
(207) 941-1298

News Archive

FDA hears concerns on new narcotic pain pill rules

Survivors of those who died from opioid overdoses urge changes in the drugs' labels, but some patients express concerns that they might have trouble getting the drugs.

Rabies vaccine stored at warmer temperatures can protect against disease, WSU research shows

A Washington State University-led research team determined rabies vaccines stored at warmer temperatures still protect against the disease in dogs.

FDA approves sNDA for pediatric autism drug ABILIFY

Bristol-Myers Squibb Company and Otsuka Pharmaceutical Co., Ltd. announced today that the U.S. Food and Drug Administration (FDA) has approved the supplemental New Drug Application (sNDA) for ABILIFY® (aripiprazole) for the treatment of irritability associated with autistic disorder in pediatric patients ages 6 to 17 years, including symptoms of aggression towards others, deliberate self-injuriousness, temper tantrums, and quickly changing moods.

SAGE launches new online resource to spotlight on research published across scholarly journals

Leading academic and professional publisher SAGE today announced the launch of a new online resource that will put the spotlight on research published across its scholarly journals.

Read more Medical News

› Verified 7 days ago


Map and Direction



NPI Associated with this Dialysis Facility:

Dialysis Facilities may have multiple NPI numbers. We have found possible NPI number/s associated with Boyd Dialysis from NPPES records by matching pattern on the basis of name, address, phone number etc. Please use this information accordingly.

NPI Number1215281712
Organization NameBoyd Dialysis
Doing Business AsTotal Renal Care Inc
Address925 Union St Bangor, Maine, 04401
Phone Number(207) 941-1298

News Archive

FDA hears concerns on new narcotic pain pill rules

Survivors of those who died from opioid overdoses urge changes in the drugs' labels, but some patients express concerns that they might have trouble getting the drugs.

Rabies vaccine stored at warmer temperatures can protect against disease, WSU research shows

A Washington State University-led research team determined rabies vaccines stored at warmer temperatures still protect against the disease in dogs.

FDA approves sNDA for pediatric autism drug ABILIFY

Bristol-Myers Squibb Company and Otsuka Pharmaceutical Co., Ltd. announced today that the U.S. Food and Drug Administration (FDA) has approved the supplemental New Drug Application (sNDA) for ABILIFY® (aripiprazole) for the treatment of irritability associated with autistic disorder in pediatric patients ages 6 to 17 years, including symptoms of aggression towards others, deliberate self-injuriousness, temper tantrums, and quickly changing moods.

SAGE launches new online resource to spotlight on research published across scholarly journals

Leading academic and professional publisher SAGE today announced the launch of a new online resource that will put the spotlight on research published across its scholarly journals.

Read more Medical News

› Verified 7 days ago


Survey of Patient's Experiences

Nephrologists Performance Ratings

Experience MeasureProviderNational Avg.
Patients who reported that nephrologists always communicated and cared for them.52%67%
Patients who reported that nephrologists usually communicated and cared for them.26%15%
Patients who reported that nephrologists sometimes or never communicated and cared for them.22%18%
Patients who gave their nephrologists a rating of 9 or 10 on a scale of 0 (worst possible) to 10 (best possible).55%60%
Patients who gave their nephrologists a rating of 7 or 8 on a scale of 0 (worst possible) to 10 (best possible).26%26%
Patients who gave their nephrologists a rating of 6 or less than 6 on a scale of 0 (worst possible) to 10 (best possible).19%14%

News Archive

FDA hears concerns on new narcotic pain pill rules

Survivors of those who died from opioid overdoses urge changes in the drugs' labels, but some patients express concerns that they might have trouble getting the drugs.

Rabies vaccine stored at warmer temperatures can protect against disease, WSU research shows

A Washington State University-led research team determined rabies vaccines stored at warmer temperatures still protect against the disease in dogs.

FDA approves sNDA for pediatric autism drug ABILIFY

Bristol-Myers Squibb Company and Otsuka Pharmaceutical Co., Ltd. announced today that the U.S. Food and Drug Administration (FDA) has approved the supplemental New Drug Application (sNDA) for ABILIFY® (aripiprazole) for the treatment of irritability associated with autistic disorder in pediatric patients ages 6 to 17 years, including symptoms of aggression towards others, deliberate self-injuriousness, temper tantrums, and quickly changing moods.

SAGE launches new online resource to spotlight on research published across scholarly journals

Leading academic and professional publisher SAGE today announced the launch of a new online resource that will put the spotlight on research published across its scholarly journals.

Read more Medical News

› Verified 7 days ago

Dialysis Center Staff Performance Ratings

Experience MeasureProviderNational Avg.
Patients who reported that dialysis center staff always communicated well, kept patients comfortable and pain-free as possible.58%62%
Patients who reported that dialysis center staff usually communicated, kept patients comfortable and pain-free as possible.20%20%
Patients who reported that dialysis center staff sometimes or never communicated, kept patients comfortable and pain-free.22%18%
Patients who gave their dialysis facility staff a rating of 9 or 10 on a scale of 0 (worst possible) to 10 (best possible).64%62%
Patients who gave their dialysis facility staff a rating of 7 or 8 on a scale of 0 (worst possible) to 10 (best possible).22%26%
Patients who gave their dialysis facility staff a rating of 6 or less than 6 on a scale of 0 (worst possible) to 10 (best possible).14%12%

News Archive

FDA hears concerns on new narcotic pain pill rules

Survivors of those who died from opioid overdoses urge changes in the drugs' labels, but some patients express concerns that they might have trouble getting the drugs.

Rabies vaccine stored at warmer temperatures can protect against disease, WSU research shows

A Washington State University-led research team determined rabies vaccines stored at warmer temperatures still protect against the disease in dogs.

FDA approves sNDA for pediatric autism drug ABILIFY

Bristol-Myers Squibb Company and Otsuka Pharmaceutical Co., Ltd. announced today that the U.S. Food and Drug Administration (FDA) has approved the supplemental New Drug Application (sNDA) for ABILIFY® (aripiprazole) for the treatment of irritability associated with autistic disorder in pediatric patients ages 6 to 17 years, including symptoms of aggression towards others, deliberate self-injuriousness, temper tantrums, and quickly changing moods.

SAGE launches new online resource to spotlight on research published across scholarly journals

Leading academic and professional publisher SAGE today announced the launch of a new online resource that will put the spotlight on research published across its scholarly journals.

Read more Medical News

› Verified 7 days ago

Overall Dialysis Center Performance Ratings

Experience MeasureProviderNational Avg.
Patients who reported that 'YES', their nephrologists and dialysis center staff provided them the information they needed to take care of them. 79%80%
Patients who reported that 'NO', their nephrologists and dialysis center staff does not provided them the information they needed to take care of them.21%20%
Patients who gave their dialysis center a rating of 9 or 10 on a scale of 0 (worst possible) to 10 (best possible).53%68%
Patients who gave their dialysis center a rating of 7 or 8 on a scale of 0 (worst possible) to 10 (best possible).27%20%
Patients who gave their dialysis center a rating of 6 or less than 6 on a scale of 0 (worst possible) to 10 (best possible).20%12%

News Archive

FDA hears concerns on new narcotic pain pill rules

Survivors of those who died from opioid overdoses urge changes in the drugs' labels, but some patients express concerns that they might have trouble getting the drugs.

Rabies vaccine stored at warmer temperatures can protect against disease, WSU research shows

A Washington State University-led research team determined rabies vaccines stored at warmer temperatures still protect against the disease in dogs.

FDA approves sNDA for pediatric autism drug ABILIFY

Bristol-Myers Squibb Company and Otsuka Pharmaceutical Co., Ltd. announced today that the U.S. Food and Drug Administration (FDA) has approved the supplemental New Drug Application (sNDA) for ABILIFY® (aripiprazole) for the treatment of irritability associated with autistic disorder in pediatric patients ages 6 to 17 years, including symptoms of aggression towards others, deliberate self-injuriousness, temper tantrums, and quickly changing moods.

SAGE launches new online resource to spotlight on research published across scholarly journals

Leading academic and professional publisher SAGE today announced the launch of a new online resource that will put the spotlight on research published across its scholarly journals.

Read more Medical News

› Verified 7 days ago

Patient Distribution

Anemia Management

Dialysis patients with Hemoglobin data95
Medicare patients who had average hemoglobin (hgb) less than 10 g/dL28

News Archive

FDA hears concerns on new narcotic pain pill rules

Survivors of those who died from opioid overdoses urge changes in the drugs' labels, but some patients express concerns that they might have trouble getting the drugs.

Rabies vaccine stored at warmer temperatures can protect against disease, WSU research shows

A Washington State University-led research team determined rabies vaccines stored at warmer temperatures still protect against the disease in dogs.

FDA approves sNDA for pediatric autism drug ABILIFY

Bristol-Myers Squibb Company and Otsuka Pharmaceutical Co., Ltd. announced today that the U.S. Food and Drug Administration (FDA) has approved the supplemental New Drug Application (sNDA) for ABILIFY® (aripiprazole) for the treatment of irritability associated with autistic disorder in pediatric patients ages 6 to 17 years, including symptoms of aggression towards others, deliberate self-injuriousness, temper tantrums, and quickly changing moods.

SAGE launches new online resource to spotlight on research published across scholarly journals

Leading academic and professional publisher SAGE today announced the launch of a new online resource that will put the spotlight on research published across its scholarly journals.

Read more Medical News

› Verified 7 days ago

Dialysis Adequacy

Adult patinets who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be atleast 1.7, that means they are receiving right amount of dialysis. Pediatric patients who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be 1.8.
Higher percentages should be better.

  • Hemodialysis
    Adult patients getting regular hemodialysis at the center140
    Adult patient months included in Kt/V greater than or equal to 1.21118
    Percentage of adult patients getting regular hemodialysis at the center93

    News Archive

    FDA hears concerns on new narcotic pain pill rules

    Survivors of those who died from opioid overdoses urge changes in the drugs' labels, but some patients express concerns that they might have trouble getting the drugs.

    Rabies vaccine stored at warmer temperatures can protect against disease, WSU research shows

    A Washington State University-led research team determined rabies vaccines stored at warmer temperatures still protect against the disease in dogs.

    FDA approves sNDA for pediatric autism drug ABILIFY

    Bristol-Myers Squibb Company and Otsuka Pharmaceutical Co., Ltd. announced today that the U.S. Food and Drug Administration (FDA) has approved the supplemental New Drug Application (sNDA) for ABILIFY® (aripiprazole) for the treatment of irritability associated with autistic disorder in pediatric patients ages 6 to 17 years, including symptoms of aggression towards others, deliberate self-injuriousness, temper tantrums, and quickly changing moods.

    SAGE launches new online resource to spotlight on research published across scholarly journals

    Leading academic and professional publisher SAGE today announced the launch of a new online resource that will put the spotlight on research published across its scholarly journals.

    Read more Medical News

    › Verified 7 days ago

  • Peritoneal Dialysis
    Adult patients getting regular peritoneal dialysis at the center24
    Adult patient months included in Kt/V greater than or equal to 1.7189
    Percentage of adult patients getting regular peritoneal dialysis at the center100

    News Archive

    FDA hears concerns on new narcotic pain pill rules

    Survivors of those who died from opioid overdoses urge changes in the drugs' labels, but some patients express concerns that they might have trouble getting the drugs.

    Rabies vaccine stored at warmer temperatures can protect against disease, WSU research shows

    A Washington State University-led research team determined rabies vaccines stored at warmer temperatures still protect against the disease in dogs.

    FDA approves sNDA for pediatric autism drug ABILIFY

    Bristol-Myers Squibb Company and Otsuka Pharmaceutical Co., Ltd. announced today that the U.S. Food and Drug Administration (FDA) has approved the supplemental New Drug Application (sNDA) for ABILIFY® (aripiprazole) for the treatment of irritability associated with autistic disorder in pediatric patients ages 6 to 17 years, including symptoms of aggression towards others, deliberate self-injuriousness, temper tantrums, and quickly changing moods.

    SAGE launches new online resource to spotlight on research published across scholarly journals

    Leading academic and professional publisher SAGE today announced the launch of a new online resource that will put the spotlight on research published across its scholarly journals.

    Read more Medical News

    › Verified 7 days ago

Mineral and Bone Disorder

An important goal of dialysis is to maintain normal levels of various minerals in the body, such as calcium. This shows the percentage of patients treated at Boyd Dialysis with elevated calcium levels.

Patients with hypercalcemia174
Hypercalcemia patient months1447
Hypercalcemia patients with serumcalcium greater than 10.2 mg3
Patients with Serumphosphor184
Patients with Serumphosphor less than 3.5 mg/dL7
Patients with Serumphosphor from 3.5 to 4.5 mg/dL29
Patients with Serumphosphor from 4.6 to 5.5 mg/dL33
Patients with Serumphosphor from 5.6 to 7 mg/dL20
Patients with Serumphosphor greater than 7 mg/dL11

News Archive

FDA hears concerns on new narcotic pain pill rules

Survivors of those who died from opioid overdoses urge changes in the drugs' labels, but some patients express concerns that they might have trouble getting the drugs.

Rabies vaccine stored at warmer temperatures can protect against disease, WSU research shows

A Washington State University-led research team determined rabies vaccines stored at warmer temperatures still protect against the disease in dogs.

FDA approves sNDA for pediatric autism drug ABILIFY

Bristol-Myers Squibb Company and Otsuka Pharmaceutical Co., Ltd. announced today that the U.S. Food and Drug Administration (FDA) has approved the supplemental New Drug Application (sNDA) for ABILIFY® (aripiprazole) for the treatment of irritability associated with autistic disorder in pediatric patients ages 6 to 17 years, including symptoms of aggression towards others, deliberate self-injuriousness, temper tantrums, and quickly changing moods.

SAGE launches new online resource to spotlight on research published across scholarly journals

Leading academic and professional publisher SAGE today announced the launch of a new online resource that will put the spotlight on research published across its scholarly journals.

Read more Medical News

› Verified 7 days ago

Vascular Access

The arteriovenous (AV) fistulae is considered long term vascular access for hemodialysis because it allows good blood flow, lasts a long time, and is less likely to get infected or cause blood clots than other types of access. Patients who don't have time to get a permanent vascular access before they start hemodialysis treatments may need to use a venous catheter as a temporary access.

Patients included in arterial venous fistula and catheter summaries 143
Patient months included in arterial venous fistula and catheter summaries 1077
Percentage of patients getting regular hemodialysis at the center that used an arteriovenous (AV) fistulae for their treatment71
Percentage of patients receiving treatment through Vascular Catheter for 90 days/longer8

News Archive

FDA hears concerns on new narcotic pain pill rules

Survivors of those who died from opioid overdoses urge changes in the drugs' labels, but some patients express concerns that they might have trouble getting the drugs.

Rabies vaccine stored at warmer temperatures can protect against disease, WSU research shows

A Washington State University-led research team determined rabies vaccines stored at warmer temperatures still protect against the disease in dogs.

FDA approves sNDA for pediatric autism drug ABILIFY

Bristol-Myers Squibb Company and Otsuka Pharmaceutical Co., Ltd. announced today that the U.S. Food and Drug Administration (FDA) has approved the supplemental New Drug Application (sNDA) for ABILIFY® (aripiprazole) for the treatment of irritability associated with autistic disorder in pediatric patients ages 6 to 17 years, including symptoms of aggression towards others, deliberate self-injuriousness, temper tantrums, and quickly changing moods.

SAGE launches new online resource to spotlight on research published across scholarly journals

Leading academic and professional publisher SAGE today announced the launch of a new online resource that will put the spotlight on research published across its scholarly journals.

Read more Medical News

› Verified 7 days ago

Hospitalization Rate

The rate of hospitalization show you whether patients who were being treated regularly at a certain dialysis center were admitted to the hospital more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other centers.

Standard Hospitalization Summary Ratio(SHR) YearJanuary, 2016 - December, 2016
Patients in facility's Hospitalization Summary160
Hospitalization Rate in facility167.5 (As Expected)
Hospitalization Rate: Upper Confidence Limit250.4
Hospitalization Rate: Lower Confidence Limit119.1

News Archive

FDA hears concerns on new narcotic pain pill rules

Survivors of those who died from opioid overdoses urge changes in the drugs' labels, but some patients express concerns that they might have trouble getting the drugs.

Rabies vaccine stored at warmer temperatures can protect against disease, WSU research shows

A Washington State University-led research team determined rabies vaccines stored at warmer temperatures still protect against the disease in dogs.

FDA approves sNDA for pediatric autism drug ABILIFY

Bristol-Myers Squibb Company and Otsuka Pharmaceutical Co., Ltd. announced today that the U.S. Food and Drug Administration (FDA) has approved the supplemental New Drug Application (sNDA) for ABILIFY® (aripiprazole) for the treatment of irritability associated with autistic disorder in pediatric patients ages 6 to 17 years, including symptoms of aggression towards others, deliberate self-injuriousness, temper tantrums, and quickly changing moods.

SAGE launches new online resource to spotlight on research published across scholarly journals

Leading academic and professional publisher SAGE today announced the launch of a new online resource that will put the spotlight on research published across its scholarly journals.

Read more Medical News

› Verified 7 days ago

Readmission Rate

The rate of readmission show you whether patients who were being treated regularly at Boyd Dialysis were readmitted more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other dialysis centers.

Standard Readmission Summary Ratio(SRR) YearJanuary, 2016 - December, 2016
Readmission Rate in facility21.6 (As Expected)
Readmission Rate: Upper Confidence Limit27.6
Readmission Rate: Lower Confidence Limit16.2

News Archive

FDA hears concerns on new narcotic pain pill rules

Survivors of those who died from opioid overdoses urge changes in the drugs' labels, but some patients express concerns that they might have trouble getting the drugs.

Rabies vaccine stored at warmer temperatures can protect against disease, WSU research shows

A Washington State University-led research team determined rabies vaccines stored at warmer temperatures still protect against the disease in dogs.

FDA approves sNDA for pediatric autism drug ABILIFY

Bristol-Myers Squibb Company and Otsuka Pharmaceutical Co., Ltd. announced today that the U.S. Food and Drug Administration (FDA) has approved the supplemental New Drug Application (sNDA) for ABILIFY® (aripiprazole) for the treatment of irritability associated with autistic disorder in pediatric patients ages 6 to 17 years, including symptoms of aggression towards others, deliberate self-injuriousness, temper tantrums, and quickly changing moods.

SAGE launches new online resource to spotlight on research published across scholarly journals

Leading academic and professional publisher SAGE today announced the launch of a new online resource that will put the spotlight on research published across its scholarly journals.

Read more Medical News

› Verified 7 days ago

Infection Rate

Hemodialysis treatment requires direct access to the bloodstream, which can be an opportunity for germs to enter the body and cause infection. This information shows how often patients at Boyd Dialysis get infections in their blood each year compared to the number of infections expected for the center based on the national average.

Standard Infection Summary Ratio(SIR) YearJanuary, 2016 - December, 2016
Infection Rate in facility.58 (As Expected)
SIR: Upper Confidence Limit1.29
SIR: Lower Confidence Limit.21

News Archive

FDA hears concerns on new narcotic pain pill rules

Survivors of those who died from opioid overdoses urge changes in the drugs' labels, but some patients express concerns that they might have trouble getting the drugs.

Rabies vaccine stored at warmer temperatures can protect against disease, WSU research shows

A Washington State University-led research team determined rabies vaccines stored at warmer temperatures still protect against the disease in dogs.

FDA approves sNDA for pediatric autism drug ABILIFY

Bristol-Myers Squibb Company and Otsuka Pharmaceutical Co., Ltd. announced today that the U.S. Food and Drug Administration (FDA) has approved the supplemental New Drug Application (sNDA) for ABILIFY® (aripiprazole) for the treatment of irritability associated with autistic disorder in pediatric patients ages 6 to 17 years, including symptoms of aggression towards others, deliberate self-injuriousness, temper tantrums, and quickly changing moods.

SAGE launches new online resource to spotlight on research published across scholarly journals

Leading academic and professional publisher SAGE today announced the launch of a new online resource that will put the spotlight on research published across its scholarly journals.

Read more Medical News

› Verified 7 days ago

Transfusion Summary

Patients with anemia require blood transfusions if their anemia is not managed well by their dialysis center. This information shows whether Boyd Dialysis's rate of transfusions is better than expected, as expected, or worse than expected, compared to other centers that treat similar patients.

Standard Transfusion Summary Ratio (STrR) Year January, 2016 - December, 2016
Patients in facility's Transfusion Summary 136
Transfusion Rate in facility16.2 (As Expected)
Transfusion Rate: Upper Confidence Limit40.4
Transfusion Rate: Lower Confidence Limit7.3

News Archive

FDA hears concerns on new narcotic pain pill rules

Survivors of those who died from opioid overdoses urge changes in the drugs' labels, but some patients express concerns that they might have trouble getting the drugs.

Rabies vaccine stored at warmer temperatures can protect against disease, WSU research shows

A Washington State University-led research team determined rabies vaccines stored at warmer temperatures still protect against the disease in dogs.

FDA approves sNDA for pediatric autism drug ABILIFY

Bristol-Myers Squibb Company and Otsuka Pharmaceutical Co., Ltd. announced today that the U.S. Food and Drug Administration (FDA) has approved the supplemental New Drug Application (sNDA) for ABILIFY® (aripiprazole) for the treatment of irritability associated with autistic disorder in pediatric patients ages 6 to 17 years, including symptoms of aggression towards others, deliberate self-injuriousness, temper tantrums, and quickly changing moods.

SAGE launches new online resource to spotlight on research published across scholarly journals

Leading academic and professional publisher SAGE today announced the launch of a new online resource that will put the spotlight on research published across its scholarly journals.

Read more Medical News

› Verified 7 days ago

Survival Summary

The rate of mortality show you whether patients who were being treated regularly at Boyd Dialysis lived longer than expected (better than expected), don’t live as long as expected (worse than expected), or lived as long as expected (as expected), compared to similar patients treated at other facilities.

Standard Survival Summary Ratio(SIR) YearJanuary, 2013 - December, 2016
Patients in facility's Survival Summary684
Mortality Rate in facility17.9 (As Expected)
Mortality Rate: Upper Confidence Limit21.5
Mortality Rate: Lower Confidence Limit14.8

News Archive

FDA hears concerns on new narcotic pain pill rules

Survivors of those who died from opioid overdoses urge changes in the drugs' labels, but some patients express concerns that they might have trouble getting the drugs.

Rabies vaccine stored at warmer temperatures can protect against disease, WSU research shows

A Washington State University-led research team determined rabies vaccines stored at warmer temperatures still protect against the disease in dogs.

FDA approves sNDA for pediatric autism drug ABILIFY

Bristol-Myers Squibb Company and Otsuka Pharmaceutical Co., Ltd. announced today that the U.S. Food and Drug Administration (FDA) has approved the supplemental New Drug Application (sNDA) for ABILIFY® (aripiprazole) for the treatment of irritability associated with autistic disorder in pediatric patients ages 6 to 17 years, including symptoms of aggression towards others, deliberate self-injuriousness, temper tantrums, and quickly changing moods.

SAGE launches new online resource to spotlight on research published across scholarly journals

Leading academic and professional publisher SAGE today announced the launch of a new online resource that will put the spotlight on research published across its scholarly journals.

Read more Medical News

› Verified 7 days ago


Dialysis Facility in Bangor, ME

Boyd Dialysis
Location: Dialysis Unit, Bangor, Maine, 04401
Phone: (207) 941-1298

News Archive

FDA hears concerns on new narcotic pain pill rules

Survivors of those who died from opioid overdoses urge changes in the drugs' labels, but some patients express concerns that they might have trouble getting the drugs.

Rabies vaccine stored at warmer temperatures can protect against disease, WSU research shows

A Washington State University-led research team determined rabies vaccines stored at warmer temperatures still protect against the disease in dogs.

FDA approves sNDA for pediatric autism drug ABILIFY

Bristol-Myers Squibb Company and Otsuka Pharmaceutical Co., Ltd. announced today that the U.S. Food and Drug Administration (FDA) has approved the supplemental New Drug Application (sNDA) for ABILIFY® (aripiprazole) for the treatment of irritability associated with autistic disorder in pediatric patients ages 6 to 17 years, including symptoms of aggression towards others, deliberate self-injuriousness, temper tantrums, and quickly changing moods.

SAGE launches new online resource to spotlight on research published across scholarly journals

Leading academic and professional publisher SAGE today announced the launch of a new online resource that will put the spotlight on research published across its scholarly journals.

Read more Medical News

› Verified 7 days ago


Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.